Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

  1. Poveda, A.
  2. Lheureux, S.
  3. Colombo, N.
  4. Cibula, D.
  5. Lindemann, K.
  6. Weberpals, J.
  7. Bjurberg, M.
  8. Oaknin, A.
  9. Sikorska, M.
  10. González-Martín, A.
  11. Madry, R.
  12. Pérez, M.J.R.
  13. Ledermann, J.
  14. Davidson, R.
  15. Blakeley, C.
  16. Bennett, J.
  17. Barnicle, A.
  18. Škof, E.
Revue:
Gynecologic Oncology

ISSN: 1095-6859 0090-8258

Année de publication: 2022

Volumen: 164

Número: 3

Pages: 498-504

Type: Article

DOI: 10.1016/J.YGYNO.2021.12.025 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable